BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6733275)

  • 1. TdT-positive acute leukemia with monocytoid characteristics: clinical, cytochemical, cytogenetic, and immunologic findings.
    Cuttner J; Seremetis S; Najfeld V; Dimitriu-Bona A; Winchester RA
    Blood; 1984 Jul; 64(1):237-43. PubMed ID: 6733275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition of AML susceptibility and classification using monoclonal antibodies.
    Seremetis S; Cuttner J; Winchester R
    Med Oncol Tumor Pharmacother; 1984; 1(4):263-7. PubMed ID: 6599464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TdT-positive acute leukemia with monocytoid characteristics. Clinical, cytochemical, cytogenetic and immunologic findings. 24 patients.
    Cuttner J; Seremetis S; Najfeld V; Troy KM; Winchester R
    Haematologica; 1987; 72(6 Suppl):113-8. PubMed ID: 3127286
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia.
    Benedetto P; Mertelsmann R; Szatrowski TH; Andreeff M; Gee T; Arlin Z; Kempin S; Clarkson B
    J Clin Oncol; 1986 Apr; 4(4):489-95. PubMed ID: 3958762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of leukemia cell terminal transferase measurements.
    McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
    Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: an indicator of response to vincristine and prednisone therapy.
    Tanaka M; Kaneda T; Hirota Y; Yoshida S; Kitajima K
    Am J Hematol; 1980; 9(3):287-93. PubMed ID: 6940442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal transferase positive acute promyelocytic leukemia: in vitro differentiation of a T-lymphocytic/promyelocytic hybrid phenotype.
    Paietta E; Dutcher JP; Wiernik PH
    Blood; 1985 Jan; 65(1):107-14. PubMed ID: 3871159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bollum enzyme in leukemia and lymphoma cells: the first decade.
    McCaffrey R; Bell R; Lillquist A; Wright G; Baril E
    Adv Exp Med Biol; 1982; 145():221-41. PubMed ID: 6956206
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of terminal transferase may predict failure of remission induction in childhood ALL.
    Shurin SB; Scillian JJ
    Blood; 1983 Jul; 62(1):81-4. PubMed ID: 6574797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TdT+/nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential stem cell.
    Paietta E; Gucalp R; Papenhausen P; Dutcher JP; Wiernik PH
    Leukemia; 1989 Jul; 3(7):485-91. PubMed ID: 2733453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluation of the periodic acid-Schiff stain in acute leukemia with immunophenotypic analyses.
    Snower DP; Smith BR; Munz UJ; McPhedran P
    Arch Pathol Lab Med; 1991 Apr; 115(4):346-50. PubMed ID: 1707262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous evaluation of terminal deoxynucleotidyl transferase and myeloperoxidase in acute leukemias using an immunocytochemical method.
    Kaplan SS; Penchansky L; Krause JR; Basford RE; Zdziarski U
    Am J Clin Pathol; 1987 Jun; 87(6):732-8. PubMed ID: 3035914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal deoxynucleotidyl transferase (TdT) in acute nonlymphocytic leukemia. A clinical, morphologic, cytochemical, immunologic, and ultrastructural study.
    McCurley TL; Greer JP; Glick AD
    Am J Clin Pathol; 1988 Oct; 90(4):421-30. PubMed ID: 2459954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of ultrastructural peroxidases and immunologic membrane markers in the diagnosis of acute leukemias.
    Marie JP; Perrot JY; Boucheix C; Zittoun J; Martyre MC; Kayibanda M; Rosenfeld C; Mishal Z; Zittoun R
    Blood; 1982 Feb; 59(2):270-6. PubMed ID: 6948582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of terminal deoxynucleotidyl transferase (TDT) in patients with leukemias and malignant lymphomas.
    Mertelsmann R
    Adv Exp Med Biol; 1982; 145():259-77. PubMed ID: 7051779
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic anemia progressing to Auer rod-positive and TdT-positive acute leukemia with 5q- chromosomal anomaly.
    Xavier AM; Kasimis BS
    Am J Hematol; 1984; 17(4):409-16. PubMed ID: 6093506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical method for the detection of terminal deoxynucleotidyl transferase in acute leukemia.
    Ho AD; Helmstädter V; Hunstein W
    Klin Wochenschr; 1982 May; 60(9):451-5. PubMed ID: 7045509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias.
    Kalwinsky DK; Weatherred WH; Dahl GV; Bowman WP; Melvin SL; Coleman MS; Bollum FJ
    Cancer Res; 1981 Jul; 41(7):2877-81. PubMed ID: 7018672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface markers in leukemia: biological and clinical correlations.
    Thiel E
    Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.